查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944410

全球出血性和缺血性中风治疗设备市场（按设备类型、治疗类型、最终用户、技术、国家和地区划分）—产业分析、市场规模、市场份额和产业预测（2025-2032年）

Hemorrhagic & Ischemic Stroke Treatment Devices Market, By Device Type, By Treatment Type, By End User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，出血性和缺血性中风治疗设备市场规模将达到 36.1098 亿美元，并预计从 2025 年到 2032 年将以 6.10% 的复合年增长率增长。

出血性和缺血性中风治疗器械是专门用于诊断、干预和治疗由脑出血（出血）或缺血（闭塞）引起的急性中风的医疗设备。这些器械包括神经血管支架、血栓切除系统、栓塞弹簧圈、血流导向装置、微导管和颅内压监测器，能够实现微创血管内手术，进而恢復血流并控制出血。现代卒中治疗器材强调精准导航、先进的影像整合、生物相容性材料和更高的安全性。创新重点在于人工智慧辅助的影像导引介入治疗、新一代血栓切除工具和增强的止血技术。人口老化和生活方式因素导致中风发病率上升，中风治疗基础设施不断完善，有利的报销政策，以及发达和新兴医疗体系中微创手术的日益普及，都为卒中治疗器械的市场发展带来了机会。

出血性和缺血性中风治疗器材市场—市场动态

市场需求受企业数位化、文件安全需求和成本效益的驱动。

企业和政府机构的数位转型正在加速对快速、安全且经济高效的列印解决方案的需求。根据IDC预测，到2023年，全球办公室列印量将超过2.3兆页，其中雷射印表机凭藉其低单页成本和在高负载环境下的耐用性将占据主导地位。安全性问题也是推动雷射印表机普及的重要因素。 IBM发布的《2024年资料外洩成本报告》显示，82%的资料外洩是由人为错误造成的，包括文件处理不当，这迫使企业部署具备安全列印释放、加密和存取控制功能的雷射列印系统。此外，预计到2024年，全球企业在託管列印服务（MPS）方面的IT支出将超过550亿美元，反映出企业正大力转向集中高效的列印管理。混合办公模式的普及和多功能雷射印表机的日益普及也在推动市场成长，因为企业越来越需要可靠、互联且节能的列印基础设施。

出血性和缺血性中风治疗设备市场—市场区隔分析：

全球出血性和缺血性中风治疗设备市场按设备类型、治疗方法、最终用户、技术和地区进行细分。

依器械类型划分，市场可分为机械血栓除去装置、动脉瘤栓塞和夹闭器械、溶栓药物传输系统、血栓摘取支架和止血器械。机械血栓除去装置因其在缺血性中风治疗中的重要作用而占据市场主导地位。根据世界卫生组织（WHO）统计，缺血性中风约占全球中风病例的65%。微创动脉瘤栓塞和夹闭器械在出血性中风的治疗中至关重要，出血性中风约占全球中风病例的30%。溶栓药物传输系统仍是缺血性中风早期治疗方法。血栓摘取支架和止血器械进一步提高了中风介入治疗的手术效果和安全性。

根据治疗类型，市场可分为缺血性中风治疗和出血性中风治疗两大板块。缺血性中风治疗板块占最大份额，这与全球缺血性中风的发生率相符。根据2021年全球疾病负担研究（GBD）的估计，全球每年新增缺血性中风病例约780万例。出血性中风治疗（包括脑出血和蜘蛛膜下腔出血）每年新增病例约400万例，并且由于用于动脉瘤治疗和出血控制的先进设备日益普及，该板块一直保持稳定增长。

出血性和缺血性中风治疗器械市场—区域分析

由于医疗基础设施发展、政府卫生政策、中风盛行率和报销政策等因素的影响，全球出血性和缺血性中风治疗设备市场存在显着的区域差异。

北美地区占最大的市场份额，这得益于其先进的医疗基础设施、微创中风治疗方法的广泛普及以及政府对中风治疗的大力投入。根据美国疾病管制与预防中心（CDC）统计，美国每年约有79.5万例新增中风病例，凸显了对先进中风治疗设备的需求。此外，联邦医疗保险（Medicare）和私人保险公司提供的神经血管介入治疗的全面保险也推动了市场成长。

欧洲的卒中发生率仅次于北美，位居第二，这主要得益于较高的公众意识、完善的卒中中心以及政府推行的早期诊断和治疗项目。根据欧洲卒中组织（ESO）统计，欧洲每年约有110万例新增卒中病例，目前各成员国正努力实现卒中诊疗的标准化。

美国出血性和缺血性中风治疗器械市场—国家分析

美国在全球出血性和缺血性中风治疗设备市场主导，这主要得益于其高昂的医疗保健支出和先进的中风护理基础设施。根据美国心臟协会（AHA）预测，到2023年，美国用于中风相关治疗和復健的医疗费用支出预计将超过460亿美元。

根据美国医疗保险和医疗补助服务中心 (CMS) 的报告，报销政策越来越重视机械取栓术和血管内治疗，截至 2022 年，全美每年大约进行 45,000 例取栓手术。此外，美国拥有 250 多个经联合委员会认证的综合中风中心，这使得尖端中风治疗设备能够迅速得到应用。

目录

第一章 出血性和缺血性中风治疗器械市场概览

  • 调查范围
  • 市场预测期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章 出血性和缺血性中风治疗器械市场：主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章 出血性和缺血性中风治疗设备产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 法规结构分析

5. 出血性和缺血性中风治疗器材市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：出血性和缺血性中风治疗器材的市场概况

  • 2024年出血性和缺血性中风治疗设备市占率分析
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 出血性和缺血性中风治疗设备市场（依设备类型划分）

  • 概述
    • 按设备类型分類的细分市场份额分析
    • 机械血栓切除装置
    • 动脉瘤栓塞及夹闭装置
    • 溶栓药物输送系统
    • 血栓摘取支架
    • 止血装置

8. 依治疗类型分類的出血性和缺血性中风治疗设备市场

  • 概述
    • 细分市场占有率分析：依治疗类型划分
    • 缺血性中风治疗
    • 出血性中风治疗

9. 依最终用户分類的出血性和缺血性中风治疗设备市场

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院
    • 门诊手术中心
    • 专科诊所

10. 依技术分類的出血性和缺血性中风治疗设备市场

  • 概述
    • 细分市场占有率分析：依技术划分
    • 基于导管的系统
    • 手术器械
    • 诊断影像和导航系统

第十一章 出血性和缺血性中风器械市场（按地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十二章 主要供应商分析－出血性和缺血性中风器械产业

  • 竞争标竿分析
    • 竞争对手仪錶板
    • 竞争定位
  • 公司简介
    • Medtronic
    • Balt
    • Terumo Corporation
    • Scientia Vascular, Inc.
    • Johnson &Johnson（MedTech）
    • MicroPort Scientific Corporation
    • phenox GmbH（Wallaby Medical）
    • B. Braun SE
    • Acandis GmbH
    • Infinity Neuro LLC
    • Integra LifeSciences
    • Penumbra, Inc.
    • Stryker
    • Boston Scientific Corporation
    • Vesalio Inc.
    • Peter LAZIC GmbH
    • 其他的

第十三章：分析师视角

简介目录
Product Code: ANV5988

Hemorrhagic & ischemic stroke treatment devices market size was valued at US$ 3,610.98 Million in 2024, expanding at a CAGR of 6.10% from 2025 to 2032.

Hemorrhagic and ischemic stroke treatment devices are specialized medical instruments designed for the diagnosis, intervention, and management of acute stroke caused by cerebral hemorrhage (bleeding) or ischemia (blockage). These devices include neurovascular stents, thrombectomy systems, embolization coils, flow diverters, microcatheters, and intracranial pressure monitors, enabling minimally invasive endovascular procedures that restore blood flow or control bleeding. Modern stroke treatment devices emphasize precision navigation, advanced imaging integration, biocompatible materials, and improved safety profiles. Innovations focus on AI-assisted image-guided interventions, next-generation thrombectomy tools, and enhanced hemostatic technologies. Market opportunities arise from growing stroke incidence due to aging populations and lifestyle factors, expanding stroke care infrastructure, favorable reimbursement policies, and increased adoption of minimally invasive procedures in both developed and emerging healthcare systems.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Market Dynamics

Growing enterprise digitization, document security needs, and cost-efficiency to propel market demand

Rising digital transformation across enterprises and government institutions is accelerating demand for high-speed, secure, and cost-efficient printing solutions. According to IDC, global office printing volumes exceeded 2.3 trillion pages in 2023, with laser printers accounting for the majority due to lower cost per page and higher durability in high-volume environments. Security concerns are also driving adoption. IBM's Cost of a Data Breach Report 2024 states that 82% of data breaches involve human error, including document mishandling, pushing organizations to adopt secure print release, encryption, and access-controlled laser printing systems. Additionally, enterprise IT spending on managed print services (MPS) crossed USD 55 billion globally in 2024, reflecting a strong shift toward centralized, efficient print management. The growing adoption of hybrid work models and multifunction laser printers further supports market growth, as organizations seek reliable, network-connected, and energy-efficient printing infrastructure.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Segmentation Analysis:

The Global Hemorrhagic & Ischemic Stroke Treatment Devices Market is segmented on the basis of Device Type, Treatment Type, End User, Technology, and Region.

Based on Device Type, the market is categorized into Mechanical Thrombectomy Devices, Aneurysm Coiling and Clipping Devices, Thrombolytic Drug Delivery Systems, Stent Retrievers, and Hemostasis Devices. Mechanical thrombectomy devices dominate the market due to their critical role in treating ischemic strokes, which constitute approximately 65% of all stroke cases globally, according to the World Health Organization (WHO). Minimally invasive aneurysm coiling and clipping devices are essential for managing hemorrhagic strokes, which make up nearly 30% of stroke cases worldwide. Thrombolytic drug delivery systems remain a standard of care for early ischemic stroke treatment. Stent retrievers and hemostasis devices further enhance procedural outcomes and safety during stroke interventions.

Based on Treatment Type, the market is divided into Ischemic Stroke Treatment and Hemorrhagic Stroke Treatment segments. The ischemic stroke treatment segment holds the largest share, consistent with the global incidence of ischemic strokes accounting for about 7.8 million new cases annually, as estimated by the Global Burden of Disease (GBD) study 2021. Hemorrhagic stroke treatment, covering intracerebral and subarachnoid hemorrhages, which together account for around 4 million new cases per year, is witnessing steady growth with rising adoption of advanced devices for aneurysm management and bleeding control.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Geographical Insights

The global hemorrhagic and ischemic stroke treatment devices market shows significant regional variation influenced by healthcare infrastructure development, government health initiatives, stroke prevalence, and reimbursement policies.

North America holds the largest market share, supported by advanced healthcare infrastructure, widespread adoption of minimally invasive stroke interventions, and strong government funding for stroke care. According to the Centers for Disease Control and Prevention (CDC), the United States reports approximately 795,000 new stroke cases annually, emphasizing the need for sophisticated stroke treatment devices. Additionally, Medicare and private insurers provide comprehensive coverage for neurovascular interventions, bolstering market growth.

Europe follows closely, driven by high awareness levels, well-established stroke centers, and government programs promoting early stroke diagnosis and treatment. The European Stroke Organisation (ESO) notes that Europe experiences about 1.1 million new stroke cases each year, with ongoing efforts to standardize stroke care across member countries.

U.S. Hemorrhagic & Ischemic Stroke Treatment Devices Market- Country Insights

The United States dominates the global hemorrhagic and ischemic stroke treatment devices market, supported by substantial healthcare expenditure and advanced stroke care infrastructure. In 2023, the U.S. healthcare spending on stroke-related treatments and rehabilitation exceeded USD 46 billion, according to the American Heart Association (AHA).

The Centers for Medicare & Medicaid Services (CMS) reports that reimbursement policies increasingly favor mechanical thrombectomy and endovascular procedures, with nearly 45,000 thrombectomy procedures performed annually across the country as of 2022. Additionally, the U.S. has over 250 Comprehensive Stroke Centers certified by The Joint Commission, enabling rapid adoption of state-of-the-art stroke intervention devices.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Competitive Landscape:

Rising stroke prevalence, technological advancements, and increasing demand for minimally invasive treatment options are intensifying competition across the global stroke treatment device ecosystem. Major players include Medtronic, Balt, Terumo Corporation, Scientia Vascular, Inc., Johnson & Johnson (MedTech), MicroPort Scientific Corporation, phenox GmbH (Wallaby Medical), B. Braun SE, and others. These companies compete through device innovation, clinical efficacy, regulatory approvals, and extensive sales and distribution networks. Common strategies include expanding portfolios of thrombectomy systems, aneurysm coiling and clipping devices, investing in AI-powered image-guided intervention technologies, and enhancing catheter and stent designs for improved patient outcomes. Many firms are also focusing on strategic partnerships with healthcare providers and research institutions to accelerate clinical trials and adoption, while emphasizing compliance with evolving global regulatory standards and reimbursement frameworks.

Recent Developments:

In January 2026, Penumbra introduced the Lightning Flash 3.0 computer assisted vacuum thrombectomy (CAVT(TM)) system, featuring enhanced clot detection, enlarged tubing, and automated backflush for faster, safer clot removal. The upgrade aims to improve procedural efficiency and fluid management, building on prior CAVT advancements in mechanical thrombectomy technology.

In February 2025, Johnson & Johnson MedTech launched the CEREGLIDE(TM) 92 Catheter System in the U.S., a next generation .092" large bore neurovascular catheter with INNERGLIDE(TM) 9 delivery aid. Designed for improved distal access and flow reduction during acute ischemic stroke interventions, it supports enhanced device navigation and integration with stroke device portfolios.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic
  • Balt
  • Terumo Corporation
  • Scientia Vascular, Inc.
  • Johnson & Johnson (MedTech)
  • MicroPort Scientific Corporation
  • phenox GmbH (Wallaby Medical)
  • B. Braun SE
  • Acandis GmbH
  • Infinity Neuro LLC
  • Integra LifeSciences
  • Penumbra, Inc.
  • Stryker
  • Boston Scientific Corporation
  • Vesalio Inc.
  • Peter LAZIC GmbH
  • Others

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Mechanical Thrombectomy Devices
  • Aneurysm Coiling and Clipping Devices
  • Thrombolytic Drug Delivery Systems
  • Stent Retrievers
  • Hemostasis Devices

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Ischemic Stroke Treatment
  • Hemorrhagic Stroke Treatment

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Catheter-Based Systems
  • Surgical Instruments
  • Imaging and Navigation Systems

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Device Type
    • 2.1.2. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Treatment Type
    • 2.1.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by End User
    • 2.1.4. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Technology
    • 2.1.5. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Country
    • 2.1.6. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemorrhagic & Ischemic Stroke Treatment Devices Key Market Trends

  • 3.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemorrhagic & Ischemic Stroke Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Opportunities
  • 3.4. Hemorrhagic & Ischemic Stroke Treatment Devices Market Future Trends

4. Hemorrhagic & Ischemic Stroke Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemorrhagic & Ischemic Stroke Treatment Devices Market Landscape

  • 6.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Device Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Device Type, 2024 & 2032 (%)
    • 7.1.2. Mechanical Thrombectomy Devices
    • 7.1.3. Aneurysm Coiling and Clipping Devices
    • 7.1.4. Thrombolytic Drug Delivery Systems
    • 7.1.5. Stent Retrievers
    • 7.1.6. Hemostasis Devices

8. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 8.1.2. Ischemic Stroke Treatment
    • 8.1.3. Hemorrhagic Stroke Treatment

9. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics

10. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 10.1.2. Catheter-Based Systems
    • 10.1.3. Surgical Instruments
    • 10.1.4. Imaging and Navigation Systems

11. Hemorrhagic & Ischemic Stroke Treatment Devices Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hemorrhagic & Ischemic Stroke Treatment Devices Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Medtronic
    • 12.2.2. Balt
    • 12.2.3. Terumo Corporation
    • 12.2.4. Scientia Vascular, Inc.
    • 12.2.5. Johnson & Johnson (MedTech)
    • 12.2.6. MicroPort Scientific Corporation
    • 12.2.7. phenox GmbH (Wallaby Medical)
    • 12.2.8. B. Braun SE
    • 12.2.9. Acandis GmbH
    • 12.2.10. Infinity Neuro LLC
    • 12.2.11. Integra LifeSciences
    • 12.2.12. Penumbra, Inc.
    • 12.2.13. Stryker
    • 12.2.14. Boston Scientific Corporation
    • 12.2.15. Vesalio Inc.
    • 12.2.16. Peter LAZIC GmbH
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us